CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 152 filers reported holding CEMPRA INC in Q3 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $20,680,000 | +46.7% | 854,564 | 0.0% | 0.20% | +28.7% |
| Q2 2016 | $14,092,000 | -5.9% | 854,564 | 0.0% | 0.16% | +1.3% |
| Q1 2016 | $14,972,000 | -42.5% | 854,564 | +2.2% | 0.16% | -38.2% |
| Q4 2015 | $26,037,000 | +11.8% | 836,382 | 0.0% | 0.25% | +17.3% |
| Q3 2015 | $23,285,000 | -27.6% | 836,382 | -10.7% | 0.21% | -3.2% |
| Q2 2015 | $32,174,000 | -7.7% | 936,382 | -7.9% | 0.22% | -13.3% |
| Q1 2015 | $34,872,000 | +22.6% | 1,016,382 | -16.0% | 0.26% | +18.6% |
| Q4 2014 | $28,435,000 | +114.5% | 1,209,506 | 0.0% | 0.22% | +100.9% |
| Q3 2014 | $13,256,000 | +2.1% | 1,209,506 | 0.0% | 0.11% | +3.9% |
| Q2 2014 | $12,978,000 | -7.1% | 1,209,506 | -0.0% | 0.10% | -15.6% |
| Q1 2014 | $13,970,000 | -6.8% | 1,209,507 | 0.0% | 0.12% | -0.8% |
| Q4 2013 | $14,986,000 | +189.6% | 1,209,507 | +168.8% | 0.12% | +223.7% |
| Q3 2013 | $5,174,000 | +48.0% | 449,884 | 0.0% | 0.04% | +46.2% |
| Q2 2013 | $3,496,000 | – | 449,884 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |